Cargando…
Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
BACKGROUND: Treatment of shigellosis in rabbits with butyrate reduces clinical severity and counteracts the downregulation of cathelicidin (CAP-18) in the large intestinal epithelia. Here, we aimed to evaluate whether butyrate can be used as an adjunct to antibiotics in the treatment of shigellosis...
Autores principales: | Raqib, Rubhana, Sarker, Protim, Mily, Akhirunnesa, Alam, Nur Haque, Arifuzzaman, Abu Saleh Mohammed, Rekha, Rokeya Sultana, Andersson, Jan, Gudmundsson, Gudmundur H, Cravioto, Alejandro, Agerberth, Birgitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447723/ https://www.ncbi.nlm.nih.gov/pubmed/22574737 http://dx.doi.org/10.1186/1471-2334-12-111 |
Ejemplares similares
-
Oral intake of phenylbutyrate with or without vitamin D(3) upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis
por: Mily, Akhirunnesa, et al.
Publicado: (2013) -
Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia
por: Sarker, Protim, et al.
Publicado: (2014) -
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
por: Mily, Akhirunnesa, et al.
Publicado: (2015) -
Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011) -
Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)